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Transmission-Ratio Distortion at Xp11.4-p21.1 in Type
1 Diabetes
To the Editor:
Naumova et al. (1998) reported a deviation from the
expected Mendelian 1:1 ratio of grandpaternal/grand-
maternal alleles at loci in Xp11.4-p21.1 in the children
of 47 families not selected on the basis of the disease
status of the children. The transmission-ratio distortion
(TRD) was found only among male offspring and was
manifested as a bias in favor of the inheritance of the
alleles of the maternal grandfather. The critical region,
containing the putative TRD locus, named “DMS1,”
was mapped to an interval bounded by DXS538 and
DXS7 and peaking at DXS1068.
These observations might have an impact on the re-
sults of a study in which we have provided evidence of
linkage to type 1 diabetes mellitus (MIM 222100), in
the same region of chromosome X (Cucca et al. 1998).
The possibility of TRD at chromosome Xp gives rise to
the question of whether the diabetes-linkage results are
indeed disease specific. The following evidence suggests
that it is highly unlikely that the DMS1 locus is respon-
sible for the chromosome Xp linkage to type 1 diabetes.
We genotyped DXS1068 (a marker that was at the
peak of our linkage curve) in two sample sets of control
families not ascertained on the basis of the disease status
of the children. These control families were from the
Centre d’Etude du Polymorphisme Humaine (Fondation
Jean Dausset/CEPH) and from a population-based sam-
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ple from the town of Busselton, Australia, and included
61 large pedigrees with 603 children and 220 families
with 525 children, respectively (Hill et al. 1995). Single-
point allele sharing in these families with multiple sib-
ships was corrected by means of the method proposed
by Hodge (1984), as implemented in the software GE-
NOME ANALYSIS SYSTEM, version 2.0. We obtained
51% sharing, by sib pairs, of one allele identical by
descent (252.6 sharing one allele and 243.4 sharing no
alleles; ). This compares with 60.5% sharing forP = .68
DXS1068 in 580 type 1 diabetic sib pair families (193
sharing one allele identical by descent and 126 sharing
no alleles in a single-point analysis; ).4P = 2 # 10
Hence, there is no evidence of TRD in these nondiabetic
families that were analyzed in the same way that we
analyzed the diabetic families.
We typed both 255 discordant (affected/unaffected)
independent sib pairs from the United Kingdom and Sar-
dinian families for DXS1068. We obtained identity-by-
descent values of 77 and 86 for sharing one and no
alleles, respectively, for all discordant pairs (47.6%); the
corresponding values were 25 and 29 for male/male pairs
only (46.3%). The trend toward !50% allele sharing in
discordant sib pairs is consistent with a type 1 diabetes–
specific effect.
The putative DMS1 TRD locus near the DXS1068
locus affects only male progeny, whereas the strongest
linkage that we observed for DXS1068 was in male/
female pairs (Cucca et al 1998). The linkage of the
DXS1068 region to type 1 diabetes was strongly con-
centrated in the 97 of 580 families that had human leu-
kocyte antigen (HLA) DR3/X (X is not DR4) sib pairs
(multipoint MLS = 3.5 at DXS1068). Some weak evi-
dence of linkage was present also in the 195 DR3/4 sib
pairs (multipoint MLS = .75 at DXS1068), and no ev-
idence of linkage was obtained in the other 288 families
with affected sib pairs (Cucca et al. 1998). We evaluated
linkage on chromosome X, conditioning the data ac-
cording to the genotype at the HLA IDDM1 major locus
on chromosome 6p21, because, in a large data set from
Sardinia, the United Kingdom, and the United States,
there was a strong increase in the male:female (M:F)
ratio, which was almost exclusively restricted to patients
with the DR3/X genotype (M:F ratio = 1.7; P = 4.7 #
), compared with a ratio of 1.0 in the DR4/Y cat-710
egory (Y is not DR3), with a small effect in DR3/4 pa-
tients (M:F ratio = 1.2; ) (Cucca et al. 1998).P = .03
Hence, both the evidence of linkage and the bias in the
M:F ratio were concentrated in the families with patients
positive for the HLA-DR3, which is one of the two main
predisposing haplotypes at the HLA/IDDM1 major lo-
cus. These data suggest an interaction between HLA-
DR3 haplotypes and the diabetes locus on chromosome
X, which is unlikely to be caused by an effect of the
putative DMS1 locus. Furthermore, both in the unaf-
fected parents and siblings of the United Kingdom and
in the Sardinian families who were DR3/3 homozygotes,
the ratio was reversed: 56 males and 80 females (0.7;
) compared with an M:F ratio of 2.2 in DR3/3P = .04
patients ( ), thereby providing another6P = 1.3 # 10
control for our results (Cucca et al. 1998).
These results indicate that it is unlikely that the type
1 diabetes linkage that we have observed is explained
by the DMS1 locus. TRD could, however, have a sig-
nificant effect on the interpretation of linkage studies of
polygenes in common diseases in which increases in al-
lele sharing at the disease locus may be very small. The
possibility of TRD should be ruled out in disease studies
(Eaves et al. 1999).
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Predominance of the T14484C Mutation in French-
Canadian Families with Leber Hereditary Optic
Neuropathy Is Due to a Founder Effect
To the Editor:
The Leber hereditary optic neuropathy (LHON) phe-
notype was first defined, more than 125 years ago, as a
maternally inherited optic neuropathy that primarily af-
fects young adult men (Leber 1871). Loss of central vi-
sion may be acute or subacute, and peripheral vision is
preserved. Slow delayed recovery can occur, but relative
central scotomata usually remain (Johns et al. 1993).
The chronic stage of LHON is characterized by optic
atrophy (MIM 535000).
LHON is associated with three primary mtDNA mu-
tations, all of which occur in genes coding for subunits
of complex I of the mitochondrial respiratory chain:
G3460A in ND1, G11778A in ND4, and T14484C in
ND6 (MIM 516006.0001) (Howell et al. 1995). All
three of these mutations alter evolutionarily conserved
amino acids and are not found in control individuals.
The relative frequency of the three primary LHON
mtDNA mutations varies considerably in different pop-
ulations, although G11778A is the most common world-
wide. We have recently found that T14484C is by far
the most common mutation in French-Canadian families
with LHON (Macmillan et al. 1998). The results of pre-
vious studies of mutation profiles of several metabolic
disorders have demonstrated founder effects, including
phenylketonuria (Rozen et al. 1994) and familial hy-
perchylomicronemia (De Braekeleer et al. 1991), in the
French-Canadian population.
To test the hypothesis that the predominance of the
T14484C mutation in French-Canadian families with
LHON is caused by a founder effect, we sequenced a
segment of the mtDNA displacement (D) loop and a
segment of the control region from French-Canadian
families with the T14484C mutation. Variation in these
noncoding regions has been used extensively to study
the evolution of modern populations. The regions se-
quenced included hypervariable regions (HVR) I and II
(Vigilant et al. 1989). The D-loop region extends from
nucleotide (nt) 189 backward through 0 to nt 16024 of
the 16,569-bp mtDNA. The control region extends from
nt 189 forward, toward the tRNAs. These two regions
contain the fastest-evolving regions of mtDNA (Upholt
and Dawid 1977), which have an estimated rate of ev-
olution that is 2.8–5 times that of the remainder of the
mitochondrial genome (Aquadro and Greenberg 1983;
Cann et al. 1984). The average nucleotide-sequence var-
iation in this region has been calculated to be 1.7%
(Aquadro and Greenberg 1983). We reviewed the re-
cords of patients with suspected LHON who were in-
dependently referred, for molecular diagnosis, to the
Montreal Neurological Hospital DNA Diagnostic Lab-
oratory. By cycle sequencing with the use of a New Eng-
land Biolabs kit (manual) or dye-labeled dideoxy ter-
minators on an ABI system (automated), we sequenced
regions that included HVR I and HVR II in the following
individuals: one member of each French-Canadian fam-
ily with the T14484C mutation, one member of a
French-Canadian family with the G11778A mutation,
and one member of a French-Canadian family without
a family history of LHON and with none of the three
primary LHON mutations. Sequencing was done in two
reactions, by use of the following primer pairs: L15996
and H16401 (which includes HVR I) and L29 and H408
(which includes HVR II; Vigilant et al. 1989). “L” refers
to “light” strand and “H” refers to “heavy” strand, and
the numbers refer to the Cambridge sequence (Anderson
et al. 1981). The institutional review boards of the Mon-
treal Neurological Hospital and the University of Illinois
at Chicago approved this study.
We analyzed 27 independently referred French-Ca-
nadian families with LHON and the T14484C mutation,
all of which were homoplasmic for the T14484C mu-
tation. We found eight homoplasmic transition muta-
tions (C16069T, T16126C, G16213A, A73G, G185A,
G228A, A263G, and C295T; table 1), compared with
the Cambridge sequence, in the families with the
T14484C mutation. Of the 27 families analyzed, 26
shared identical substitutions at all eight sites that were
different from the Cambridge sequence. Six of these mu-
tations were found only in families with the T14484C
mutation and not in either the family with the G11778A
family or the family without LHON (table 1). The mu-
tated sites were distributed throughout the D-loop and
control region: one was located in the large central con-
served sequence block (CSB; A73G), one (G228A) was
in CSB 1, two (T16126C and G16213A) were in HVR
I, three (G185A, A263G, and C295T) were in HVR II,
and one (C16069T) was just outside HVR I.
In addition, 22/27 families with LHON and the
T14484C mutation had a C insertion in the homopoly-
meric stretch of C’s before the T at position 310. All 27
